<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7118541/results/search/disease/results.xml">
  <result pre="tiotropium bromide may also be effective for SARS-CoV-2. Abstract The" exact="infection" post="of a novel coronavirus found in Wuhan of China"/>
  <result pre="(MT-DTI) to identify commercially available drugs that could act on" exact="viral" post="proteins of SARS-CoV-2. The result showed that atazanavir, an"/>
  <result pre="an antiretroviral medication used to treat and prevent the human" exact="immunodeficiency" post="virus (HIV), is the best chemical compound, showing an"/>
  <result pre="Interestingly, lopinavir, ritonavir, and darunavir are all designed to target" exact="viral" post="proteinases. However, in our prediction, they may also bind"/>
  <result pre="the family Coronaviridae, are positive-sense enveloped RNA viruses and cause" exact="infections" post="in birds, mammals, and humans [1], [2], [3]. The"/>
  <result pre="genera, such as Alphacoronavirus, Betacoronavirus, Deltacoronavirus, and Gammacoronavirus[4]. Two infamous" exact="infectious" post="coronaviruses in the genus Betacoronavirus are severe acute respiratory"/>
  <result pre="Two infamous infectious coronaviruses in the genus Betacoronavirus are severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) [5] and Middle East respiratory"/>
  <result pre="infamous infectious coronaviruses in the genus Betacoronavirus are severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) [5] and Middle East respiratory syndrome"/>
  <result pre="infectious coronaviruses in the genus Betacoronavirus are severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) [5] and Middle East respiratory syndrome coronavirus"/>
  <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) [5] and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) [6], which have infected more than"/>
  <result pre="acute respiratory syndrome coronavirus (SARS-CoV) [5] and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) [6], which have infected more than 10,000"/>
  <result pre="as the previous outbreak due to a recent epidemic of" exact="atypical" post="pneumonia (designated as coronavirus disease 2019; COVID-19) caused by"/>
  <result pre="the previous outbreak due to a recent epidemic of atypical" exact="pneumonia" post="(designated as coronavirus disease 2019; COVID-19) caused by a"/>
  <result pre="due to a recent epidemic of atypical pneumonia (designated as" exact="coronavirus disease" post="2019; COVID-19) caused by a novel coronavirus (severe acute"/>
  <result pre="to a recent epidemic of atypical pneumonia (designated as coronavirus" exact="disease" post="2019; COVID-19) caused by a novel coronavirus (severe acute"/>
  <result pre="coronavirus disease 2019; COVID-19) caused by a novel coronavirus (severe" exact="acute" post="respiratory syndrome coronavirus 2; SARS-CoV-2) in Wuhan, China [5],"/>
  <result pre="disease 2019; COVID-19) caused by a novel coronavirus (severe acute" exact="respiratory" post="syndrome coronavirus 2; SARS-CoV-2) in Wuhan, China [5], [9]."/>
  <result pre="2019; COVID-19) caused by a novel coronavirus (severe acute respiratory" exact="syndrome" post="coronavirus 2; SARS-CoV-2) in Wuhan, China [5], [9]. SARS-CoV-2,"/>
  <result pre="on average after infection. This is relatively slower than severe" exact="acute" post="respiratory syndrome (SARS), which was caused by SARS-CoV [10]."/>
  <result pre="average after infection. This is relatively slower than severe acute" exact="respiratory" post="syndrome (SARS), which was caused by SARS-CoV [10]. During"/>
  <result pre="after infection. This is relatively slower than severe acute respiratory" exact="syndrome" post="(SARS), which was caused by SARS-CoV [10]. During the"/>
  <result pre="genomic RNA (gRNA), 2) proteolysis of the translated polyprotein with" exact="viral" post="3C-like proteinase, 3) replication of gRNA with the viral"/>
  <result pre="with viral 3C-like proteinase, 3) replication of gRNA with the" exact="viral" post="replication complex that consists of RNA-dependent RNA polymerase (RdRp),"/>
  <result pre="3′-to-5′ exonuclease, endoRNAse, and 2′-O-ribose methyltransferase, and 4) assembly of" exact="viral" post="components [11]. These replication-associated proteins are the primary targets"/>
  <result pre="assembly of viral components [11]. These replication-associated proteins are the" exact="primary" post="targets of post-entry treatment drugs to suppress viral replication."/>
  <result pre="are the primary targets of post-entry treatment drugs to suppress" exact="viral" post="replication. Although much intensive effort is being made worldwide"/>
  <result pre="identify commercially available antiviral drugs that could potentially disrupt SARS-CoV-2′s" exact="viral" post="components, such as proteinase, RNA-dependent RNA polymerase, and/or helicase."/>
  <result pre="do not have experimentally confirmed 3D crystal structures, such as" exact="viral" post="proteins of SARS-CoV-2. We share a list of top"/>
  <result pre="were screened for antiviral drugs that are FDA approved, target" exact="viral" post="proteins, and have a Kd value &amp;lt; 1000 nM."/>
  <result pre="algorithms showed moderate similarities (higher is better for MT-DTI, whereas" exact="lower" post="is better for AutoDock Vina) were observed in both"/>
  <result pre="the inhibitory potency of lopinavir [27]. According to the prediction," exact="viral" post="proteinase-targeting drugs were predicted to act more favorably on"/>
  <result pre="proteinase-targeting drugs were predicted to act more favorably on the" exact="viral" post="replication process than viral proteinase through the DTI model"/>
  <result pre="to act more favorably on the viral replication process than" exact="viral" post="proteinase through the DTI model (Table 2, Table 3,"/>
  <result pre="study may be useful to control unexpected and rapidly spreading" exact="infections" post="such SARS-CoV, Middle East respiratory syndrome (MERS-CoV), and SARS-CoV-2"/>
  <result pre="control unexpected and rapidly spreading infections such SARS-CoV, Middle East" exact="respiratory" post="syndrome (MERS-CoV), and SARS-CoV-2 at the frontline of the"/>
  <result pre="unexpected and rapidly spreading infections such SARS-CoV, Middle East respiratory" exact="syndrome" post="(MERS-CoV), and SARS-CoV-2 at the frontline of the disease"/>
  <result pre="respiratory syndrome (MERS-CoV), and SARS-CoV-2 at the frontline of the" exact="disease" post="control until better therapeutic measures are developed. Several recent"/>
  <result pre="drugs (rapamycin and everolimus) and a drug (tiotropium bromide) for" exact="asthma" post="and chronic obstructive pulmonary disease (COPD) were identified as"/>
  <result pre="and everolimus) and a drug (tiotropium bromide) for asthma and" exact="chronic" post="obstructive pulmonary disease (COPD) were identified as promising candidates"/>
  <result pre="and a drug (tiotropium bromide) for asthma and chronic obstructive" exact="pulmonary disease" post="(COPD) were identified as promising candidates by MT-DTI. In"/>
  <result pre="a drug (tiotropium bromide) for asthma and chronic obstructive pulmonary" exact="disease" post="(COPD) were identified as promising candidates by MT-DTI. In"/>
  <result pre="drug (tiotropium bromide) for asthma and chronic obstructive pulmonary disease" exact="(COPD)" post="were identified as promising candidates by MT-DTI. In contrast,"/>
  <result pre="and a shareholder in, Deargen Inc. References References 1CavanaghD.Coronavirus avian" exact="infectious" post="bronchitis virusVet Res38200728129717296157 2LimY.X.NgY.L.TamJ.P.LiuD.X.Human coronaviruses: a review of virus-host"/>
  <result pre="a shareholder in, Deargen Inc. References References 1CavanaghD.Coronavirus avian infectious" exact="bronchitis" post="virusVet Res38200728129717296157 2LimY.X.NgY.L.TamJ.P.LiuD.X.Human coronaviruses: a review of virus-host interactionsDiseases432016"/>
  <result pre="and bioinformatics analysisViruses220101804182021994708 5KuikenT.FouchierR.A.SchuttenM.RimmelzwaanG.F.van AmerongenG.van RielD.Newly discovered coronavirus as the" exact="primary" post="cause of severe acute respiratory syndromeLancet362200326327012892955 6ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of"/>
  <result pre="AmerongenG.van RielD.Newly discovered coronavirus as the primary cause of severe" exact="acute" post="respiratory syndromeLancet362200326327012892955 6ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from"/>
  <result pre="RielD.Newly discovered coronavirus as the primary cause of severe acute" exact="respiratory" post="syndromeLancet362200326327012892955 6ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a"/>
  <result pre="6ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.FouchierR.A.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN Engl J Med36720121814182023075143 7WHO. Summary of"/>
  <result pre="July 2003. Dec 31, 2003. (https://wwwwhoint/csr/sars/country/table2004_04_21/en/). 2020. 8WHO. Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). November, 2019. (http://wwwwhoint/emergencies/mers-cov/en/). 2020. 9LiQ.GuanX.WuP.WangX.ZhouL.TongY.Early transmission"/>
  <result pre="2003. Dec 31, 2003. (https://wwwwhoint/csr/sars/country/table2004_04_21/en/). 2020. 8WHO. Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). November, 2019. (http://wwwwhoint/emergencies/mers-cov/en/). 2020. 9LiQ.GuanX.WuP.WangX.ZhouL.TongY.Early transmission dynamics"/>
  <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 33HolshueM.L.DeBoltC.LindquistS.LofyK.H.WiesmanJ.BruceH.First case"/>
  <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 33HolshueM.L.DeBoltC.LindquistS.LofyK.H.WiesmanJ.BruceH.First case of"/>
  <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020 33HolshueM.L.DeBoltC.LindquistS.LofyK.H.WiesmanJ.BruceH.First case of 2019"/>
  <result pre="characteristics and therapeutic procedure for four cases with 2019 novel" exact="coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends1412020646832037389 35MaxmenA.More"/>
  <result pre="and therapeutic procedure for four cases with 2019 novel coronavirus" exact="pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends1412020646832037389 35MaxmenA.More"/>
  <result pre="supported by a grant from the National R&amp;amp;D Program for" exact="Cancer" post="Control, Ministry of Health &amp;amp; Welfare, Republic of Korea"/>
 </snippets>
</snippetsTree>
